BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37041410)

  • 1. VprBP/DCAF1 regulates p53 function and stability through site-specific phosphorylation.
    Ghate NB; Kim S; Mehmood R; Shin Y; Kim K; An W
    Oncogene; 2023 Apr; 42(17):1405-1416. PubMed ID: 37041410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VprBP/DCAF1 Triggers Melanomagenic Gene Silencing through Histone H2A Phosphorylation.
    Shin Y; Kim S; Liang G; Ulmer TS; An W
    Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VprBP/DCAF1 triggers melanomagenic gene silencing through histone H2A phosphorylation.
    Shin Y; Kim S; Liang G; Ulmer TS; An W
    Res Sq; 2023 Jul; ():. PubMed ID: 37293029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail.
    Kim K; Heo K; Choi J; Jackson S; Kim H; Xiong Y; An W
    Mol Cell Biol; 2012 Feb; 32(4):783-96. PubMed ID: 22184063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer.
    Ghate NB; Kim S; Shin Y; Kim J; Doche M; Valena S; Situ A; Kim S; Rhie SK; Lenz HJ; Ulmer TS; Mumenthaler SM; An W
    Nat Commun; 2023 Apr; 14(1):2140. PubMed ID: 37069142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer.
    Ghate NB; Kim S; Spiller E; Kim S; Shin Y; Rhie SK; Smbatyan G; Lenz HJ; Mumenthaler SM; An W
    Mol Oncol; 2021 Oct; 15(10):2801-2817. PubMed ID: 34312968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VPRBP Functions Downstream of the Androgen Receptor and OGT to Restrict p53 Activation in Prostate Cancer.
    Poulose N; Forsythe N; Polonski A; Gregg G; Maguire S; Fuchs M; Minner S; Sauter G; McDade SS; Mills IG
    Mol Cancer Res; 2022 Jul; 20(7):1047-1060. PubMed ID: 35348747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VprBP has intrinsic kinase activity targeting histone H2A and represses gene transcription.
    Kim K; Kim JM; Kim JS; Choi J; Lee YS; Neamati N; Song JS; Heo K; An W
    Mol Cell; 2013 Nov; 52(3):459-67. PubMed ID: 24140421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode.
    Wang D; Kon N; Lasso G; Jiang L; Leng W; Zhu WG; Qin J; Honig B; Gu W
    Nature; 2016 Oct; 538(7623):118-122. PubMed ID: 27626385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interplay between p53 acetylation and H1.2 phosphorylation in p53-regulated transcription.
    Kim K; Jeong KW; Kim H; Choi J; Lu W; Stallcup MR; An W
    Oncogene; 2012 Sep; 31(39):4290-301. PubMed ID: 22249259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VprBP (DCAF1) Regulates RAG1 Expression Independently of Dicer by Mediating RAG1 Degradation.
    Schabla NM; Perry GA; Palmer VL; Swanson PC
    J Immunol; 2018 Aug; 201(3):930-939. PubMed ID: 29925675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
    Lee JH; Kim HS; Lee SJ; Kim KT
    J Cell Sci; 2007 Jul; 120(Pt 13):2259-71. PubMed ID: 17591690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VprBP/DCAF1 Regulates the Degradation and Nonproteolytic Activation of the Cell Cycle Transcription Factor FoxM1.
    Wang X; Arceci A; Bird K; Mills CA; Choudhury R; Kernan JL; Zhou C; Bae-Jump V; Bowers A; Emanuele MJ
    Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VprBP mitigates TGF-β and Activin signaling by promoting Smurf1-mediated type I receptor degradation.
    Li Y; Cui C; Xie F; Kiełbasa S; Mei H; van Dinther M; van Dam H; Bauer A; Zhang L; Ten Dijke P
    J Mol Cell Biol; 2020 Feb; 12(2):138-151. PubMed ID: 31291647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53.
    Reed SM; Hagen J; Tompkins VS; Thies K; Quelle FW; Quelle DE
    Cell Cycle; 2014; 13(8):1288-98. PubMed ID: 24621507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage-induced regulatory interplay between DAXX, p53, ATM kinase and Wip1 phosphatase.
    Brazina J; Svadlenka J; Macurek L; Andera L; Hodny Z; Bartek J; Hanzlikova H
    Cell Cycle; 2015; 14(3):375-87. PubMed ID: 25659035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection.
    Srivastava S; Swanson SK; Manel N; Florens L; Washburn MP; Skowronski J
    PLoS Pathog; 2008 May; 4(5):e1000059. PubMed ID: 18464893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of p53 serine 15 increases interaction with CBP.
    Lambert PF; Kashanchi F; Radonovich MF; Shiekhattar R; Brady JN
    J Biol Chem; 1998 Dec; 273(49):33048-53. PubMed ID: 9830059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity.
    Turenne GA; Price BD
    BMC Cell Biol; 2001; 2():12. PubMed ID: 11483158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer.
    Ali A; Bhatti MZ; Shah AS; Duong HQ; Alkreathy HM; Mohammad SF; Khan RA; Ahmad A
    J Biol Chem; 2015 Aug; 290(35):21336-51. PubMed ID: 25911104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.